Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis
-
- S. Deitelzweig
- Ochsner Clinic Foundation, Department of Hospital Medicine, New Orleans, LA, USA;
-
- C. Farmer
- Evidera Inc., London, UK;
-
- X. Luo
- Pfizer, Inc., New York, NY, USA;
-
- X. Li
- Bristol-Myers Squibb, Lawrenceville, NJ, USA;
-
- L. Vo
- Bristol-Myers Squibb, Lawrenceville, NJ, USA;
-
- J. Mardekian
- Pfizer, Inc., New York, NY, USA;
-
- K. Fahrbach
- Evidera, Inc., Waltham, MA, USA
-
- A. Ashaye
- Evidera, Inc., Waltham, MA, USA
Journal
-
- Current Medical Research and Opinion
-
Current Medical Research and Opinion 34 (3), 487-498, 2017-12-08
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1360292620810944384
-
- ISSN
- 14734877
- 03007995
-
- Data Source
-
- Crossref